Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V J Barrett

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
American Journal of Clinical Pathology|December 9, 1998
More data on Chagas diseaseV J Barrett, J F Turrens
Eye (London, England)|December 16, 2000
Bilateral pre-retinal macular haemorrhage following blunt head injuryV J Barrett, R G Collyer-Powell
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 1, 1987
Comparative analysis of two types of 5-hydroxytryptamine receptor mediating vasorelaxation: differential classification using tryptaminesG R Martin, P Leff, D Cambridge, et al.
British Journal of Pharmacology|March 1, 1986
Pharmacological analysis of the interaction between Bay K 8644 and 5-HT in rabbit aortaV J Barrett, P Leff, G R Martin, et al.
Immunohematology|January 1, 1995
Analysis of the routine use of polyethylene glycol (PEG) as an enhancement mediumV J Barrett, J R Stubbs, K Stuardi, et al.
Immunohematology|January 1, 1996
Anti-Holley detected in a primary immune responseV J Barrett, M M O'Brien, J J Moulds, et al.
British Journal of Pharmacology|May 1, 1997
Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan)G R Martin, A D Robertson, S J MacLennan, et al.
Neurogastroenterology and Motility|June 3, 1999
The pharmacological properties of the novel selective 5-HT3 receptor antagonist, alosetron, and its effects on normal and perturbed small intestinal transit in the fasted ratN M Clayton, R Sargent, A Butler, et al.
American Journal of Clinical Pathology|November 14, 1997
Negligible prevalence of antibodies against Trypanosoma cruzi among blood donors in the southeastern United StatesV J Barrett, D A Leiby, J L Odom, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
American Journal of Clinical Pathology|December 9, 1998
More data on Chagas diseaseV J Barrett, J F Turrens
Eye (London, England)|December 16, 2000
Bilateral pre-retinal macular haemorrhage following blunt head injuryV J Barrett, R G Collyer-Powell
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 1, 1987
Comparative analysis of two types of 5-hydroxytryptamine receptor mediating vasorelaxation: differential classification using tryptaminesG R Martin, P Leff, D Cambridge, et al.
British Journal of Pharmacology|March 1, 1986
Pharmacological analysis of the interaction between Bay K 8644 and 5-HT in rabbit aortaV J Barrett, P Leff, G R Martin, et al.
Immunohematology|January 1, 1995
Analysis of the routine use of polyethylene glycol (PEG) as an enhancement mediumV J Barrett, J R Stubbs, K Stuardi, et al.
Immunohematology|January 1, 1996
Anti-Holley detected in a primary immune responseV J Barrett, M M O'Brien, J J Moulds, et al.
British Journal of Pharmacology|May 1, 1997
Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan)G R Martin, A D Robertson, S J MacLennan, et al.
Neurogastroenterology and Motility|June 3, 1999
The pharmacological properties of the novel selective 5-HT3 receptor antagonist, alosetron, and its effects on normal and perturbed small intestinal transit in the fasted ratN M Clayton, R Sargent, A Butler, et al.
American Journal of Clinical Pathology|November 14, 1997
Negligible prevalence of antibodies against Trypanosoma cruzi among blood donors in the southeastern United StatesV J Barrett, D A Leiby, J L Odom, et al.
Pageof 1